| Q34446347 | 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner |
| Q52023039 | A 5-arm maze enables parallel measures of sustained visuo-spatial attention and spatial working memory in mice. |
| Q46246563 | A clinical pharmacological study of subcutaneous nicotine |
| Q41097681 | A comparison of the attentional and consolidation hypotheses for the facilitation of memory by nicotine |
| Q50744430 | A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder. |
| Q43857751 | A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task |
| Q36494896 | A touch screen-automated cognitive test battery reveals impaired attention, memory abnormalities, and increased response inhibition in the TgCRND8 mouse model of Alzheimer's disease |
| Q41454730 | Acetylcholine, aging, and Alzheimer's disease |
| Q36106834 | Acetylcholinergic neurotransmission and the beta-amyloid cascade: implications for Alzheimer's disease |
| Q37878781 | Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification |
| Q52081361 | Acute nicotinic blockade produces cognitive impairment in normal humans. |
| Q72638647 | Advances in the pharmacotherapy of Alzheimer's disease |
| Q36830205 | Alterations in Cholinergic Pathways and Therapeutic Strategies Targeting Cholinergic System after Traumatic Brain Injury |
| Q34160761 | Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies |
| Q30952093 | Animal paradigms to assess cognition with translation to humans |
| Q50655751 | Aortic stiffness is an indicator of cognitive dysfunction before and after aortic valve replacement for aortic stenosis. |
| Q39916503 | Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit |
| Q35675412 | Association between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample |
| Q39151452 | Association between microstructural integrity of frontostriatal tracts and school functioning: ADHD symptoms and executive function as mediators |
| Q87314176 | Attention |
| Q38897372 | Attention and the Cholinergic System: Relevance to Schizophrenia |
| Q34023931 | Attention as a target of intoxication: insights and methods from studies of drug abuse |
| Q73222827 | Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease |
| Q36252844 | Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I. |
| Q71283690 | Behaviour-related effects of nicotine on slow EEG waves in basal nucleus-lesioned rats |
| Q37206660 | Beneficial effects of nicotine |
| Q33837663 | Both a nicotinic single nucleotide polymorphism (SNP) and a noradrenergic SNP modulate working memory performance when attention is manipulated |
| Q44171276 | Brain-selective stimulation of nicotinic receptors by TC-1734 enhances ACh transmission from frontoparietal cortex and memory in rodents |
| Q29308426 | CNVs conferring risk of autism or schizophrenia affect cognition in controls |
| Q49160155 | Caffeine and nicotine improve visual tracking by rats: a comparison with amphetamine, cocaine and apomorphine |
| Q47444108 | Changes in cognitive functioning in sick-listed participants in occupational rehabilitation: A feasibility study |
| Q41122353 | Cholinergic activity and constraints on information processing |
| Q37217895 | Cholinergic components of frontal lobe function and dysfunction |
| Q36705328 | Cholinergic grafts, memory and ageing |
| Q34677583 | Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention |
| Q52110964 | Cholinergic-rich transplants alleviate cognitive deficits in lesioned rats, but exacerbate response to cholinergic drugs. |
| Q57074621 | Cholinomimetics and Alzheimer's disease |
| Q44176755 | Chromaproline and Chromaperidine, nicotine agonists, and Donepezil, cholinesterase inhibitor, enhance performance of memory tasks in ovariectomized rats. |
| Q37214396 | Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats. |
| Q44611321 | Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment |
| Q46792317 | Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome |
| Q52228711 | Chronic treatments with cholinoceptor drugs influence spatial learning in rats. |
| Q51597211 | Clonidine and diazepam have differential effects on tests of attention and learning. |
| Q40943329 | Cognition enhancers in age-related cognitive decline |
| Q41376834 | Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease |
| Q38156249 | Cognitive impairment in depression: a systematic review and meta-analysis |
| Q44199597 | Cognitive mechanisms of nicotine on visual attention |
| Q37238551 | Cognitive neuroscience and brain imaging in bipolar disorder. |
| Q30840035 | Cognitive outcomes in early-treated adults with phenylketonuria (PKU): A comprehensive picture across domains |
| Q34262772 | Cognitive screening and neuropsychological assessment in early Alzheimer's disease |
| Q51114760 | Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear. |
| Q40984457 | Conformationally restricted analogues of nicotine and anabasine. |
| Q42423885 | Corticothalamic network dysfunction and behavioral deficits in a mouse model of Alzheimer's disease |
| Q48097064 | Counteractive effects of a partial (sabcomeline) and a full (RS86) muscarinic receptor agonist on deficits in radial maze performance induced by S-AMPA lesions of the basal forebrain and medial septal area |
| Q36729485 | Cytoskeletal transport in the aging brain: focus on the cholinergic system |
| Q60325187 | Development of a pharmacological target profile for muscarinic agonists |
| Q44701963 | Diazepam produces disinhibitory cognitive effects in male volunteers. |
| Q43815545 | Different pharmacokinetics of nicotine following intravenous administration of nicotine base and nicotine hydrogen tartarate in rats |
| Q34863670 | Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohort |
| Q42470408 | Differential changes of nicotinic receptors in the rat brain following ibotenic acid and 192-IgG saporin lesions of the nucleus basalis magnocellularis |
| Q43833022 | Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice. |
| Q52102330 | Distinguishing between attentional and amnestic effects in information processing: the separate and combined effects of scopolamine and nicotine on verbal free recall. |
| Q45826934 | Disturbed microstructural integrity of the frontostriatal fiber pathways and executive dysfunction in children with attention deficit hyperactivity disorder. |
| Q40923282 | Does nicotine have beneficial effects in the treatment of certain diseases? |
| Q57404014 | Effect of haloperidol on nicotine-induced enhancement of vigilance in human subjects |
| Q43543591 | Effect of nicotine and tacrine on acetylcholine release from rat cerebral cortical slices |
| Q57822469 | Effect of smoking cessation on the risk of dementia: a longitudinal study |
| Q52144163 | Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. |
| Q52170973 | Effects of acute nicotine on several operant behaviors in rats. |
| Q52046529 | Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. |
| Q36923811 | Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system--I. Amelioration of cognitive deficits by transplants into cortex and hippocampus but not into basa |
| Q42469079 | Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system--II. Cholinergic drugs as probes to investigate lesion-induced deficits and transplant-induced func |
| Q52057314 | Effects of disrupting the cholinergic system on short-term spatial memory in rats. |
| Q71759906 | Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex |
| Q48905551 | Effects of modafinil on cognitive functions in first episode psychosis |
| Q52110197 | Effects of nicotine, oxotremorine and 9-amino 1,2,3,4- tetrahydroacridine (tacrine) on matching and non matching to position in rats: no evidence for mnemonic enhancement. |
| Q41676772 | Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats |
| Q52081590 | Effects of physostigmine on stimulus encoding in a memory-scanning task |
| Q35618922 | Emerging therapeutics for Alzheimer's disease: an avenue of hope |
| Q40056642 | Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms. |
| Q28591352 | Executive and social behaviors under nicotinic receptor regulation |
| Q48337914 | Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease. |
| Q50925741 | Factors associated with cognitive impairment among older Italian inpatients. Gruppo Italiano di Farmacovigilanza nell'Anziano (G.I.F.A.). |
| Q34427157 | Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo |
| Q41099297 | Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. |
| Q49496990 | Galantamine and Computerized Cognitive Behavioral Therapy for Cocaine Dependence: A Randomized Clinical Trial |
| Q35953418 | Galantamine improves sustained attention in chronic cocaine users. |
| Q34002746 | Genetic dissection of nicotine-related behaviour: a review of animal studies |
| Q93050940 | Healthy Subjects With Extreme Patterns of Performance Differ in Functional Network Topology and Benefits From Nicotine |
| Q43942893 | Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory |
| Q29544057 | Hot and cold cognition in unmedicated depressed subjects with bipolar disorder |
| Q34142038 | Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum |
| Q34732823 | Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: rescue by donepezil (Aricept). |
| Q28270639 | Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement |
| Q43256690 | Improvement of executive functions in boys with attention deficit hyperactivity disorder: an open-label follow-up study with once-daily atomoxetine |
| Q52165565 | Increased acetylcholine release in the rat medial prefrontal cortex during performance of a visual attentional task. |
| Q52914035 | Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli |
| Q40504983 | Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies |
| Q24598925 | Leveraging the cortical cholinergic system to enhance attention |
| Q58701511 | MAP1B mutations cause intellectual disability and extensive white matter deficit |
| Q28263028 | Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders |
| Q28333982 | Memory and attention in patients with senile dementia of the Alzheimer type and in normal elderly subjects |
| Q52080368 | Memory modulation with peripherally acting cholinergic drugs |
| Q83225255 | MouseBytes, an open-access high-throughput pipeline and database for rodent touchscreen-based cognitive assessment |
| Q48146837 | Multiple neuronal networks mediate sustained attention |
| Q48212126 | Neural correlates of atomoxetine improving inhibitory control and visual processing in Drug-naïve adults with attention-deficit/hyperactivity disorder |
| Q50694397 | Neural correlates of inhibitory control and visual processing in youths with attention deficit hyperactivity disorder: a counting Stroop functional MRI study. |
| Q49113328 | Neuropharmacology. Psychoactive smoke |
| Q47781525 | Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression |
| Q48165530 | Nicotine enhancement of contextual fear conditioning |
| Q34604413 | Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia |
| Q44558645 | Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training |
| Q52169195 | Nicotine enhances stimulus detection performance of middle- and old-aged rats: a longitudinal study. |
| Q48819691 | Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety |
| Q44607180 | Nicotine produces a within-subject enhancement of contextual fear conditioning in C57BL/6 mice independent of sex |
| Q48638027 | Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors |
| Q34959810 | Nicotine's oxidative and antioxidant properties in CNS. |
| Q28139928 | Nicotine, brain nicotinic receptors, and neuropsychiatric disorders |
| Q73184554 | Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice |
| Q41659796 | Nicotinic acetylcholine receptors in health and disease |
| Q52053272 | Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing. |
| Q30372351 | Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders |
| Q30450602 | Nicotinic modulation of innate immune pathways via α7 nicotinic acetylcholine receptor |
| Q24532028 | Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders |
| Q38345699 | Nicotinic receptors and attention |
| Q36828916 | Nicotinic receptors in neurodegeneration |
| Q52081673 | Nicotinic systems and cognitive function |
| Q44371405 | Nicotinic-glutamatergic interactions and attentional performance on an operant visual signal detection task in female rats |
| Q45245244 | Nicotinic-serotonergic drug interactions and attentional performance in rats |
| Q57477243 | Non-smokers show acute tolerance to subcutaneous nicotine |
| Q52056873 | Nootropic effect of nicotine on carbon monoxide (CO)-induced delayed amnesia in mice. |
| Q73405619 | Occupancy of brain nicotinic acetylcholine receptors by nicotine doses equivalent to those obtained when smoking a cigarette |
| Q41713078 | Panic disorder: a theoretical synthesis of medical and psychological approaches |
| Q48678313 | Pavlov's methodological behaviorism as a pre-Socratic contribution of the melding of the differential and experimental psychology. |
| Q47755412 | Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study |
| Q40955351 | Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders |
| Q47655831 | Profiling attention and cognition enhancing drugs in a rat touchscreen-based continuous performance test |
| Q73526453 | Prolonged delivery of nicotine in rats via nasal administration of proliposomes |
| Q52023506 | Protractive effects of chronic treatment with an acutely sub-toxic regimen of diisopropylflurophosphate on the expression of cholinergic receptor densities in rats. |
| Q44464113 | Psychoactive drugs and pilot performance: a comparison of nicotine, donepezil, and alcohol effects |
| Q50795704 | Psychomotor performance in smokers following single and repeated doses of nicotine gum |
| Q35741065 | Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. |
| Q36972884 | Psychopharmacology in the 1990s. What does the future hold for the aged patient? |
| Q73045276 | Quantitative structure-activity relationships of nicotine analogues as neuronal nicotinic acetylcholine receptor ligands |
| Q43471356 | Rapid visual information processing as a cognitive endophenotype of attention deficit hyperactivity disorder |
| Q33638243 | Reappraising neurotransmitter-based strategies |
| Q48399841 | Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine |
| Q35179835 | Relation between nicotine intake and Alzheimer's disease |
| Q44362490 | Reversal of a vigilance decrement in the aged rat by subtype-selective nicotinic ligands |
| Q52508441 | Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. |
| Q44554999 | Role of central cholinergic receptor sub-types in spatial working memory: a five-arm maze task in mice provides evidence for a functional role of nicotinic receptors in mediating trace access processes |
| Q24561894 | Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review |
| Q45014348 | Separate and combined effects of the social drugs on psychomotor performance |
| Q34392360 | Sex differences in brain and behavior: emphasis on nicotine, nitric oxide and place learning. |
| Q54053220 | Sexually dimorphic effect of an acute smoking manipulation on skin resistance but not on heart-rate during a cognitive verbal task. |
| Q58089183 | Specific Basal Forebrain-Cortical Cholinergic Circuits Coordinate Cognitive Operations |
| Q51814865 | Speed of processing and executive functions in adults with phenylketonuria: Quick in finding the word, but not the ladybird. |
| Q41676201 | Studies on choline transport enhancement into fibroblasts from normals and Alzheimer's donors |
| Q52120601 | Sustained attention deficit in bipolar disorder is not a working memory impairment in disguise. |
| Q36656541 | Sustained attention in mild Alzheimer's disease |
| Q34324800 | TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects. |
| Q52144183 | TC-2559: a novel orally active ligand selective at neuronal acetylcholine receptors. |
| Q35561661 | Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkers |
| Q92973684 | The Arctic/Swedish APP mutation alters the impact of chronic stress on cognition in mice |
| Q35844510 | The Influence of Pathologies upon Sensory Perception and Sensory Coordination in Children with Developmental Dyslexia and Learning Disorders: A Unified Theory of Developmental Dyslexia |
| Q64251410 | The Toxins of Nemertean Worms |
| Q49130443 | The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type |
| Q52274270 | The biological, social and clinical bases of drug addiction: commentary and debate. |
| Q40861115 | The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems |
| Q36978299 | The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls |
| Q36978294 | The effects of acute tryptophan depletion and serotonin transporter polymorphism on emotional processing in memory and attention |
| Q42464534 | The effects of cholinergic drugs and cholinergic-rich foetal neural transplants on alcohol-induced deficits in radial maze performance in rats |
| Q77646622 | The effects of nicotine on spatial and non-spatial expectancies in a covert orienting task |
| Q74239216 | The effects of nicotine on the 13 Hz steady-state visually evoked potential |
| Q26799352 | The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people |
| Q43991249 | The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets |
| Q38446238 | The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment |
| Q33887372 | The nicotinic acetylcholine receptor: smoking and Alzheimer's disease revisited |
| Q71004677 | The norepinephrine transporter gene modulates intrinsic brain activity, visual memory, and visual attention in children with attention-deficit/hyperactivity disorder |
| Q34041867 | The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins |
| Q36507405 | The role of nicotine and nicotinic mechanisms in neuropsychiatric disease |
| Q52210284 | The selective 5-HT3 receptor antagonist, WAY100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system. |
| Q47426188 | The warrior in the machine: neuroscience goes to war. |
| Q41376826 | Trans-synaptic stimulation of cortical acetylcholine and enhancement of attentional functions: a rational approach for the development of cognition enhancers |
| Q34093995 | Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches? |
| Q48258271 | Truncating mutations in RBM12 are associated with psychosis |
| Q43857738 | Ventral hippocampal alpha 7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze |
| Q73109584 | Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory |
| Q50311934 | Visual memory and sustained attention impairment in youths with autism spectrum disorders. |
| Q37465460 | nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms. |